epinephrine: be contraindicated in diabetes

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents medication
Weight: 0.66
, chemical
Weight: 0.63
, neurotransmitter
Weight: 0.60
, vasoconstrictor
Weight: 0.60
, hormone
Weight: 0.57
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.36
, corticosteroid
Weight: 0.36
, antihistamine
Weight: 0.36

Related properties

Property Similarity
be contraindicated in diabetes 1.00
be contraindicated in asthma 0.95
be contraindicated in glaucoma 0.94
be contraindicated in epiglottitis 0.94
be contraindicated in patients 0.94
be contraindicated in pregnancy 0.94
be contraindicated in infections 0.93
be contraindicated in porphyria 0.92
be contraindicated in infants 0.91
be contraindicated in asthmatic patients 0.91

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.10
Rule weight: 0.13
Evidence weight: 0.78
Similarity weight: 0.94
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.41
¬ Remarkable(ibuprofen, be contraindicated in pregnancy)
0.10
Rule weight: 0.13
Evidence weight: 0.79
Similarity weight: 0.91
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.38
¬ Remarkable(ibuprofen, be contraindicated in infants)
0.09
Rule weight: 0.13
Evidence weight: 0.77
Similarity weight: 0.91
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.43
¬ Remarkable(ibuprofen, be contraindicated in asthmatic patients)
0.09
Rule weight: 0.13
Evidence weight: 0.68
Similarity weight: 0.95
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.59
¬ Remarkable(ibuprofen, be contraindicated in asthma)
0.08
Rule weight: 0.13
Evidence weight: 0.60
Similarity weight: 0.95
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.74
¬ Remarkable(antihistamine, be contraindicated in asthma)
0.07
Rule weight: 0.13
Evidence weight: 0.59
Similarity weight: 0.94
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.75
¬ Remarkable(antihistamine, be contraindicated in glaucoma)
0.07
Rule weight: 0.13
Evidence weight: 0.57
Similarity weight: 0.92
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.79
¬ Remarkable(phenobarbital, be contraindicated in porphyria)
0.07
Rule weight: 0.13
Evidence weight: 0.55
Similarity weight: 0.93
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.84
¬ Remarkable(corticosteroid, be contraindicated in infections)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.93
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.84
Remarkable(corticosteroid, be contraindicated in infections)
Evidence: 0.54
¬ Plausible(corticosteroid, be contraindicated in infections)
0.55
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.95
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.74
Remarkable(antihistamine, be contraindicated in asthma)
Evidence: 0.86
¬ Plausible(antihistamine, be contraindicated in asthma)
0.54
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.94
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.75
Remarkable(antihistamine, be contraindicated in glaucoma)
Evidence: 0.78
¬ Plausible(antihistamine, be contraindicated in glaucoma)
0.54
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.92
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.79
Remarkable(phenobarbital, be contraindicated in porphyria)
Evidence: 0.52
¬ Plausible(phenobarbital, be contraindicated in porphyria)
0.53
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.95
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.59
Remarkable(ibuprofen, be contraindicated in asthma)
Evidence: 0.79
¬ Plausible(ibuprofen, be contraindicated in asthma)
0.51
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.41
Remarkable(ibuprofen, be contraindicated in pregnancy)
Evidence: 0.79
¬ Plausible(ibuprofen, be contraindicated in pregnancy)
0.50
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.91
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.38
Remarkable(ibuprofen, be contraindicated in infants)
Evidence: 0.71
¬ Plausible(ibuprofen, be contraindicated in infants)
0.49
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.91
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.43
Remarkable(ibuprofen, be contraindicated in asthmatic patients)
Evidence: 0.85
¬ Plausible(ibuprofen, be contraindicated in asthmatic patients)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.85
¬ Salient(epinephrine, be contraindicated in diabetes)

Similarity expansion

0.77
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.94
Evidence: 0.87
Typical(epinephrine, be contraindicated in diabetes)
Evidence: 0.38
¬ Typical(epinephrine, be contraindicated in epiglottitis)
0.72
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.94
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.53
¬ Plausible(epinephrine, be contraindicated in epiglottitis)
0.71
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.85
Salient(epinephrine, be contraindicated in diabetes)
Evidence: 0.77
¬ Salient(epinephrine, be contraindicated in epiglottitis)
0.47
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.94
Evidence: 0.54
Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.90
¬ Remarkable(epinephrine, be contraindicated in epiglottitis)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.85
Salient(epinephrine, be contraindicated in diabetes)
Evidence: 0.87
¬ Typical(epinephrine, be contraindicated in diabetes)
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.80
Plausible(epinephrine, be contraindicated in diabetes)
Evidence: 0.87
¬ Typical(epinephrine, be contraindicated in diabetes)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.76
Similarity weight: 0.93
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.45
¬ Typical(corticosteroid, be contraindicated in infections)
0.09
Rule weight: 0.14
Evidence weight: 0.75
Similarity weight: 0.92
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.46
¬ Typical(phenobarbital, be contraindicated in porphyria)
0.07
Rule weight: 0.14
Evidence weight: 0.58
Similarity weight: 0.94
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.78
¬ Typical(antihistamine, be contraindicated in glaucoma)
0.07
Rule weight: 0.14
Evidence weight: 0.54
Similarity weight: 0.95
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.85
¬ Typical(ibuprofen, be contraindicated in asthma)
0.07
Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 0.95
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.88
¬ Typical(antihistamine, be contraindicated in asthma)
0.07
Rule weight: 0.14
Evidence weight: 0.54
Similarity weight: 0.91
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.85
¬ Typical(ibuprofen, be contraindicated in infants)
0.06
Rule weight: 0.14
Evidence weight: 0.51
Similarity weight: 0.94
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.91
¬ Typical(ibuprofen, be contraindicated in pregnancy)
0.06
Rule weight: 0.14
Evidence weight: 0.49
Similarity weight: 0.91
Evidence: 0.54
¬ Remarkable(epinephrine, be contraindicated in diabetes)
Evidence: 0.95
¬ Typical(ibuprofen, be contraindicated in asthmatic patients)